The South African government says it could fill the potential gap in the number of doses it will need of the twice-yearly HIV ...

Twenty-five years ago, South Africans battled for ARVs to keep people alive. Now the focus has shifted to medicines that can prevent HIV altogether. Health Beat looks at Aids at 44 — and how the story ...

Although a new draft Tobacco Bill for South Africa was published in 2018 to get the country’s nicotine habit under control, ...

Obesity is surging in South Africa. What’s fuelling this epidemic and how does it contribute to diabetes and heart disease, SA’s top killers?

We tell a good story with the science to back it. Support great journalism today.

In the eight years since the Gauteng health department ended its contract with a private psychiatric hospital group, Life Esidimeni, to look after long-term state mental health patients, a tragedy of ...

South Africa has become the first African country — and our medicines regulator the third worldwide — to register the revolutionary twice-a-year anti-HIV jab, lenacapavir (LEN). The shot could bring ...

South Africa has close to 700 medical doctors who haven’t been able to find a job in the public sector since qualifying. The shrinking health budget, coupled with rising salaries and high medical ...

Professors Hoosen Coovadia and Salim Abdool Karim, two of SA's foremost HIV researchers, were recently the health department's greatest enemies.

Gilead Sciences, the maker of a twice-a year anti-HIV injection, has approached South Africa’s medicine regulator to discuss how to get the shot registered locally as fast as possible in the country.

In today’s newsletter, Tanya Pampalone tells us why we need our educators to better understand how to work with disabilities.

On Saturday, the US state department issued details of who qualifies for a limited waiver during the Trump administration’s 90-day pause of foreign aid. The freeze has resulted in the temporary close ...